rs924607
|
|
|
0.720 |
GeneticVariation |
BEFREE |
Therefore, the aim of this study was to determine whether the CEP72 rs924607 TT genotype is a useful marker of vincristine neuropathy during induction therapy among Spanish children with B-ALL treated on the LAL-SHOP protocols.
|
26618658 |
2016 |
rs924607
|
|
|
0.720 |
GeneticVariation |
BEFREE |
Among patients with the high-risk CEP72 genotype (TT at rs924607), 28 of 50 (56%; 95% CI, 41.2%-70.0%) developed at least 1 episode of grade 2 to 4 neuropathy, a higher rate than in patients with the CEP72 CC or CT genotypes (58/271 patients [21.4%; 95% CI, 16.9%-26.7%]; P = 2.4×10(-6)).
|
25710658 |
2015 |
rs924607
|
|
T |
0.720 |
GeneticVariation |
GWASCAT |
Among patients with the high-risk CEP72 genotype (TT at rs924607), 28 of 50 (56%; 95% CI, 41.2%-70.0%) developed at least 1 episode of grade 2 to 4 neuropathy, a higher rate than in patients with the CEP72 CC or CT genotypes (58/271 patients [21.4%; 95% CI, 16.9%-26.7%]; P = 2.4×10(-6)).
|
25710658 |
2015 |
rs10555080
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies.
|
31127053 |
2019 |
rs11073752
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies.
|
31127053 |
2019 |
rs12137595
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Modifier Gene Candidates in Charcot-Marie-Tooth Disease Type 1A: A Case-Only Genome-Wide Association Study.
|
30958311 |
2019 |
rs13417783
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies.
|
31127053 |
2019 |
rs1858826
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.
|
29278617 |
2018 |
rs11154178
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A genome-wide association study suggests that MAPK14 is associated with diabetic foot ulcers.
|
28672053 |
2017 |
rs28485846
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A genome-wide association study suggests that MAPK14 is associated with diabetic foot ulcers.
|
28672053 |
2017 |
rs3761980
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A genome-wide association study suggests that MAPK14 is associated with diabetic foot ulcers.
|
28672053 |
2017 |
rs71597855
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A genome-wide association study suggests that MAPK14 is associated with diabetic foot ulcers.
|
28672053 |
2017 |
rs80028505
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
A genome-wide association study suggests that MAPK14 is associated with diabetic foot ulcers.
|
28672053 |
2017 |
rs11017056
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
|
27143689 |
2016 |
rs875858
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
|
27143689 |
2016 |
rs12786200
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
|
25710658 |
2015 |
rs17032980
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
|
25710658 |
2015 |
rs4463516
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
|
25710658 |
2015 |
rs7818688
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
|
25710658 |
2015 |
rs10495970
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
|
24554482 |
2014 |
rs10509586
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
|
24554482 |
2014 |
rs12722486
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
|
24554482 |
2014 |
rs1330950
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
|
24554482 |
2014 |
rs1514687
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
|
24554482 |
2014 |
rs17108344
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
|
24554482 |
2014 |